After very careful consideration of current conditions, we have decided to postpone the Chicago Paragraph IV Disputes Master Symposium until the fall of 2021. We are also moving the New York Paragraph IV Disputes conference from August 20-21, 2020 to October 6-7, 2020.
Additionally, in response to your requests, we are pleased to let you know that we will be holding a one-day virtual conference on the impact of COVID-19 on Paragraph IV litigation on August 20th, entitled: Paragraph IV on Trial: COVID-19 Edition.
Master the Skills Needed to Overcome the Challenges of Modern Paragraph IV Litigation
Each fall, leading pharmaceutical patent litigators for brand name and generic drug companies gather at the Paragraph IV Disputes Master Symposium in Chicago to receive up-to-the-minute information on the latest developments affecting Hatch-Waxman litigation and participate in significant peer-to-peer networking opportunities.
As the industry prepares to address the fallout of global pharmaceutical patent losses of billions of dollars and the impact of evolving law, regulation and policy impacting the Hatch-Waxman landscape, the time for this conference has never been more relevant.
WHO YOU WILL MEET
Patent attorneys and litigators (in-house & law firms) who represent:
- Brand name pharmaceutical companies
- Generic pharmaceutical companies
- Biopharmaceutical companies
This is the best high-level conference on Paragraph IV disputes…
…the smaller breakout sessions allow participants to tailor their conference experience to meet their specific needs, and exchange ideas in an intimate and dynamic environment
Attend the conference that the “Who’s Who” of Hatch-Waxman litigators have designated as the forum which sets the standards for Paragraph IV practice. Register now and be part of the prestigious meeting of the minds.